Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Reexamination Certificate
2005-10-25
2005-10-25
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
C514S184000, C514S185000, C514S186000, C514S188000, C514S334000, C514S822000, C514S824000, C514S863000, C514S866000, C514S883000, C514S908000, C514S912000, C514S954000, C424S646000
Reexamination Certificate
active
06958359
ABSTRACT:
Vanadium compounds for inhibiting angiogenesis useful for treating or preventing diabetic retinopathy, hemangiomas, cancers with abnormal blood vessel supply, restenosis following vascular injury, and the like.
REFERENCES:
patent: 4559157 (1985-12-01), Smith et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4820508 (1989-04-01), Wortzman
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 5648382 (1997-07-01), Billington et al.
patent: 5871779 (1999-02-01), Cruz
patent: WO 99/36063 (1999-07-01), None
patent: WO 00/27389 (2000-05-01), None
patent: WO 00/35930 (2000-06-01), None
Doyle et al.,Inorg. Chem.,7: 2479-2484, 1968.
Mullins et al., 1994,Arterioscler. Thromb.,14: 1047-1055.
Wilkinson et al.,J. Am. Chem. Soc.,76: 4281-4284, 1954.
Auerbach et al,Developmental Biology,41:39, 1974.
Benyumov et al,Rus. J. Dev. Biol.,26(2):132, 1995
Cahill et al,Nature,392: 300-303, 1998.
Evans,J Chem Soc,2003, 1959.
Folkman,Ann Surg,175:409, 1972.
Folkman et al,Science,235:442, 1985.
Folkman,Nat. Med.,1:27, 1995.
Ghosh et al,Clinc Canc Res,6:1536, 2000.
Gimbrane et al,J Exp Med,136:261, 1972.
Gorbsky et al,Bioessays,19: 193-197, 1997.
Hardwick, K. G.,Trends Genet.,14: 1-4, 1998.
Hoyt et al,Cell,66: 507-517, 1991.
Hyde, Rev Sci Instrum, 43: 629, 1972.
Kimmel et al,Dev. Dynam.,203:253, 1995.
Kopf-Maier, et al,J Cancer Res. Clin. Onccol.,106: 44-52, 1983.
Landzberg, et. al., 1997,Prog. Cardiovascular Diseases,39:361-298.
Li et al,Cell,66: 519-531, 1991.
Mullins et al., 1994,Arterioscler. Thromb.,14:1047-1055.
Nguyen et al,Microvascular Research,47:31, 1994.
Sakurai, et. al.,BBRC,206: 133, 1995.
Taylar et al,Nature,297:307, 1982.
Ueda et al., 1995,Coron. Artery Dis.,6:71-81.
Vaitkus, P.T., 1995,Coron. Atery Dis.,6:429-439.
Westerfield,The Zebrafish Book,1993, 2d Edition Univ. of Oregon Press, Eugene.
Mullins et al., 1994,Arterioscler. Thromb.,14:1047-1055.
Merchant & Gould P.C.
Pak John
Parker Hughes Institute
LandOfFree
Vanadium compounds as anti-angiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vanadium compounds as anti-angiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vanadium compounds as anti-angiogenic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3492747